Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRentokil Initial Regulatory News (RTO)

Share Price Information for Rentokil Initial (RTO)

Share Price is delayed by 15 minutes
Get Live Data
427.20    -1.80 (-0.42%)
Bid:
427.00
Ask:
427.30
Spread: 0.30 (0.07%)
Market Cap: £10.75b
RTO Live PriceLast checked at - London Stock Exchange

Intraday Rentokil Initial Share Chart

Pre stabilisation notice - Rentokil Initial Plc

20 Jun 2022 09:12

RNS Number : 4527P
ING Bank N.V. London Branch
20 June 2022
 

Pré - Stabilisation Notice

ING Bank N.V. (contact: Kris Devos; telephone: 0032 2 557 16 01) hereby gives notice that the Stabilising Manager named below may stabilise the offer of the following securities in accordance with Commission Regulation (EC) No. 2273/2003 implementing the Market Abuse Directive (2003/6/EC).

 

The securities:

Issuer:

Rentokil Initial Plc

Guarantor (if any):

N/A

Aggregate nominal amount:

N/A

Description:

GBP 10yr

Offer price:

Stabilisation:

Stabilising Manager:

ING Groep

Stabilisation period expected to start on:

20/06/2022

Stabilisation period expected to end no later than:

30 days after the proposed issue date of the securities.

Existence, maximum size and conditions of use of over-allotment facility:

The Stabilising Manager may over-allot the securities to the extent permitted in accordance with applicable law.

 

In connection with the offer of the above securities, the Stabilising Manager(s) may over-allot the securities or effect transactions with a view to supporting the market price of the securities at a level higher than that which might otherwise prevail. However, there is no assurance that the Stabilising Manager(s) will take any stabilisation action and any stabilisation action, if begun, may be ended at any time. Any stabilisation action or over-allotment shall be conducted in accordance with all applicable laws and rules.

 

This announcement is for information purposes only and does not constitute an invitation or offer to underwrite, subscribe for or otherwise acquire or dispose of any securities of the Issuer in any jurisdiction.

 

This announcement and the offer of the securities to which it relates are only addressed to and directed at persons outside the United Kingdom and persons in the United Kingdom who have professional experience in matters related to investments or who are high net worth persons within article 12(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 and must not be acted on or relied on by other persons in the United Kingdom10.

In addition, if and to the extent that this announcement is communicated in, or the offer of the securities to which it relates is made in, any EEA Member State that has implemented

 

Directive 2003/71/EC (together with any applicable implementing measures in any Member State, the "Prospectus Directive") before the publication of a prospectus in relation to the securities which has been approved by the competent authority in that Member State in accordance with the Prospectus Directive (or which has been approved by a competent authority in another Member State and notified to the competent authority in that Member State in accordance with the Prospectus Directive), this announcement and the offer are only addressed to and directed at persons in that Member State who are qualified investors within the meaning of the Prospectus Directive (or who are other persons to whom the offer may lawfully be addressed) and must not be acted on or relied on by other persons in that Member State.

 

This announcement is not an offer of securities for sale into the United States. The securities have not been, and will not be, registered under the United States Securities Act of 1933 and may not be offered or sold in the United States absent registration or an exemption from registration. There will be no public offer of securities in the United States.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
SSDGZGZVRGRGZZG
Date   Source Headline
7th Mar 20061:38 pmRNSAcquisition
3rd Mar 200610:33 amRNSMTN Programme
1st Mar 200610:45 amRNSAcquisition
23rd Feb 20067:02 amRNSFinal Results
20th Feb 20063:40 pmRNSStatement re Head Office
8th Feb 20067:00 amRNSStatement re Manned Guarding
25th Jan 200610:00 amRNSClosure of Activity
24th Jan 20067:01 amRNSAcquisition
6th Jan 20064:08 pmRNSHolding(s) in Company
21st Dec 20053:42 pmRNSEMTN Programmes
19th Dec 200510:25 amRNSPension Scheme Deficit
9th Dec 20055:48 pmRNSPublication of Prospectus
6th Dec 20054:12 pmRNSDisposal
29th Nov 20057:03 amRNSDisposal of Style Conferences
7th Nov 20052:08 pmRNSHolding(s) in Company
3rd Nov 20057:01 amRNSTrading Statement
1st Nov 200511:13 amRNSHolding(s) in Company
26th Oct 20052:51 pmRNSTrading Statement
25th Oct 20052:35 pmRNSHolding(s) in Company
25th Oct 20057:00 amRNSInitial City Link
21st Oct 20051:33 pmRNSResponse to Raphoe
20th Oct 200510:00 amRNSDirectorate Change
18th Oct 20053:18 pmRNSEPT Disclosure - Amendment
18th Oct 20052:26 pmRNSEPT Disclosure - Amendment
18th Oct 200511:00 amRNSRule 8.3- Rentokil Init PLC
17th Oct 20052:00 pmRNSResponse to Raphoe
17th Oct 200511:48 amRNSRule 8.3- Rentokil Init PLC
17th Oct 200511:43 amRNSEPT Disclosure
14th Oct 200512:02 pmRNSEPT Disclosure - CFD
14th Oct 200511:43 amRNSEPT Disclosure
14th Oct 200511:20 amRNSRule 8.3- Rentokil Initial
14th Oct 20057:00 amRNSRule 8.3- Summary
13th Oct 20056:25 pmRNSRule 8.3-Rentokil Initial PLC
13th Oct 20055:32 pmRNSEPT Disclosure - Amendment
13th Oct 200511:40 amRNSEPT Disclosure
12th Oct 20053:23 pmRNSEPT Disclosure - Amendment
12th Oct 200511:55 amRNSRule 8.3- Rentokil Initial pl
12th Oct 200511:37 amRNSEPT Disclosure
12th Oct 200511:17 amRNSRule 8.3- Rentokil Initial
12th Oct 200511:07 amRNSRule 8.3 Rentokil Initial PLC
12th Oct 20059:45 amRNSRule 8.3-Rentokil Initial PLC
11th Oct 200511:17 amRNSEPT Disclosure
10th Oct 200512:12 pmRNSEPT Disclosure - CFD
10th Oct 200511:25 amRNSEPT Disclosure
7th Oct 20056:12 pmRNSEPT Disclosure - Amendment
7th Oct 20053:23 pmRNSEPT Disclosure - Amendment
7th Oct 200511:39 amRNSEPT Disclosure
7th Oct 200511:28 amRNSRule 8.3-Rentokil Initial PLC
7th Oct 200511:03 amRNSRule 8.3- Rentokil Init PLC
7th Oct 20058:49 amRNSRule 8.3-Rentokil Initial PLC

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.